,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,83160,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538,G6PC1,9606,Homo sapiens (human),Vanillin binds to G6PC1 protein,,,PMID:33823243,https://www.ncbi.nlm.nih.gov/pubmed/33823243,33823243,,
1,83301,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539,G6PD,9606,Homo sapiens (human),Vanillin inhibits the reaction [cadmium chloride results in decreased activity of G6PD protein],,,PMID:37336463,https://www.ncbi.nlm.nih.gov/pubmed/37336463,37336463,,
2,83302,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597,GAPDH,9606,Homo sapiens (human),Vanillin inhibits the reaction [cadmium chloride results in decreased activity of GAPDH protein],,,PMID:37336463,https://www.ncbi.nlm.nih.gov/pubmed/37336463,37336463,,
3,83303,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729,GCLC,9606,Homo sapiens (human),Vanillin results in increased expression of GCLC mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
4,83304,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730,GCLM,9606,Homo sapiens (human),Vanillin results in increased expression of GCLM mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
5,83305,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739,GLO1,9606,Homo sapiens (human),Vanillin inhibits the reaction [cadmium chloride results in decreased activity of GLO1 protein],,,PMID:37336463,https://www.ncbi.nlm.nih.gov/pubmed/37336463,37336463,,
6,83306,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,9606,Homo sapiens (human),Vanillin inhibits the reaction [cadmium chloride results in decreased activity of GSR protein],,,PMID:37336463,https://www.ncbi.nlm.nih.gov/pubmed/37336463,37336463,,
7,83307,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,9606,Homo sapiens (human),Vanillin results in increased expression of HMOX1 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
8,83308,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251,HPRT1,9606,Homo sapiens (human),Vanillin results in decreased mutagenesis of HPRT1 gene,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
9,83309,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3304,HSPA1B,https://ctdbase.org/detail.go?type=gene&acc=3304,,,3304,HSPA1B,9606,Homo sapiens (human),Vanillin results in increased expression of HSPA1B mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
10,83310,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593,IL12B,9606,Homo sapiens (human),"Vanillin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
11,83311,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606,IL18,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [cisplatin results in increased expression of IL18 protein]|vanillin inhibits the reaction [methotrexate results in increased expression of IL18 protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
12,83484,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mrna],,,PMID:26296324,https://www.ncbi.nlm.nih.gov/pubmed/26296324,26296324,,
13,83485,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mrna],,,PMID:26296324,https://www.ncbi.nlm.nih.gov/pubmed/26296324,26296324,,
14,83486,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3638,INSIG1,https://ctdbase.org/detail.go?type=gene&acc=3638,,,3638,INSIG1,9606,Homo sapiens (human),Vanillin results in decreased expression of INSIG1 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
15,83487,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3727,JUND,https://ctdbase.org/detail.go?type=gene&acc=3727,,,3727,JUND,9606,Homo sapiens (human),Vanillin results in decreased expression of JUND mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
16,83488,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934,LCN2,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [cisplatin results in increased expression of LCN2 protein]|vanillin inhibits the reaction [methotrexate results in increased expression of LCN2 protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
17,83489,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605,MAP2K2,9606,Homo sapiens (human),Vanillin results in decreased expression of MAP2K2 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
18,83490,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,57787,MARK4,https://ctdbase.org/detail.go?type=gene&acc=57787,,,57787,MARK4,9606,Homo sapiens (human),Vanillin results in decreased expression of MARK4 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
19,83491,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,17748,MT1,https://ctdbase.org/detail.go?type=gene&acc=17748,,,17748,Mt1,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mrna],,,PMID:27074584,https://www.ncbi.nlm.nih.gov/pubmed/27074584,27074584,,
20,83492,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,17750,MT2,https://ctdbase.org/detail.go?type=gene&acc=17750,,,17750,Mt2,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mrna],,,PMID:27074584,https://www.ncbi.nlm.nih.gov/pubmed/27074584,27074584,,
21,83493,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,4502,MT2A,https://ctdbase.org/detail.go?type=gene&acc=4502,,,4502,MT2A,9606,Homo sapiens (human),Vanillin results in increased expression of MT2A mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
22,83494,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843,NOS2,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [cisplatin results in increased expression of NOS2 protein]|vanillin inhibits the reaction [methotrexate results in increased expression of NOS2 protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
23,83634,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,5514,PPP1R10,https://ctdbase.org/detail.go?type=gene&acc=5514,,,5514,PPP1R10,9606,Homo sapiens (human),Vanillin results in decreased expression of PPP1R10 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
24,83635,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna],,,PMID:17465205,https://www.ncbi.nlm.nih.gov/pubmed/17465205,17465205,,
25,83636,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mrna],,,PMID:26296324,https://www.ncbi.nlm.nih.gov/pubmed/26296324,26296324,,
26,83637,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836,PYGL,9606,Homo sapiens (human),Vanillin binds to PYGL protein,,,PMID:33823243,https://www.ncbi.nlm.nih.gov/pubmed/33823243,33823243,,
27,83638,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [methotrexate results in increased expression of RELA protein]|vanillin inhibits the reaction [cisplatin results in increased expression of RELA protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
28,83639,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,11046,SLC35D2,https://ctdbase.org/detail.go?type=gene&acc=11046,,,11046,SLC35D2,9606,Homo sapiens (human),Vanillin results in decreased expression of SLC35D2 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
29,83640,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657,SLC7A11,9606,Homo sapiens (human),Vanillin results in increased expression of SLC7A11 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
30,83641,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,7041,TGFB1I1,https://ctdbase.org/detail.go?type=gene&acc=7041,,,7041,TGFB1I1,9606,Homo sapiens (human),Vanillin results in decreased expression of TGFB1I1 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
31,83642,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),"Vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
32,83643,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mrna],,,PMID:26296324,https://www.ncbi.nlm.nih.gov/pubmed/26296324,26296324,,
33,83644,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [cisplatin results in increased expression of TNF protein]|vanillin inhibits the reaction [methotrexate results in increased expression of TNF protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
34,83786,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Vanillin results in decreased expression of TP53 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
35,83787,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,10626,TRIM16,https://ctdbase.org/detail.go?type=gene&acc=10626,,,10626,TRIM16,9606,Homo sapiens (human),Vanillin results in increased expression of TRIM16 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
36,83788,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360,UGP2,9606,Homo sapiens (human),Vanillin results in increased expression of UGP2 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
37,83789,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,54659,UGT1A3,https://ctdbase.org/detail.go?type=gene&acc=54659,,,54659,UGT1A3,9606,Homo sapiens (human),UGT1A3 protein results in increased glucuronidation of vanillin,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
38,83790,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577,UGT1A7,9606,Homo sapiens (human),UGT1A7 protein results in increased glucuronidation of vanillin,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
39,83791,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577,UGT1A7,9986,Oryctolagus cuniculus (rabbit),UGT1A7 protein results in increased glucuronidation of vanillin,,,PMID:9264550,https://www.ncbi.nlm.nih.gov/pubmed/9264550,9264550,,
40,83792,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,54576,UGT1A8,https://ctdbase.org/detail.go?type=gene&acc=54576,,,54576,UGT1A8,9606,Homo sapiens (human),UGT1A8 protein results in increased glucuronidation of vanillin,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
41,83793,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575,UGT1A10,9606,Homo sapiens (human),UGT1A10 protein results in increased glucuronidation of vanillin,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
42,83794,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,162514,TRPV3,https://ctdbase.org/detail.go?type=gene&acc=162514,,,162514,TRPV3,10090,Mus musculus (house mouse),Vanillin results in increased activity of TRPV3 protein,,,PMID:16617338,https://www.ncbi.nlm.nih.gov/pubmed/16617338,16617338,,
43,105298,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43,ACHE,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [[fructose co-treated with streptozocin] results in increased expression of ACHE protein],,,PMID:33823243,https://www.ncbi.nlm.nih.gov/pubmed/33823243,33823243,,
44,105299,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646,AKR1C2,9606,Homo sapiens (human),Vanillin results in increased expression of AKR1C2 mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
45,105300,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,759,CA1,https://ctdbase.org/detail.go?type=gene&acc=759,,,759,CA1,9606,Homo sapiens (human),Vanillin results in decreased activity of CA1 protein,,,PMID:19231207,https://www.ncbi.nlm.nih.gov/pubmed/19231207,19231207,,
46,105301,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,760,CA2,https://ctdbase.org/detail.go?type=gene&acc=760,,,760,CA2,9606,Homo sapiens (human),Vanillin results in decreased activity of CA2 protein,,,PMID:19231207,https://www.ncbi.nlm.nih.gov/pubmed/19231207,19231207,,
47,105302,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [methotrexate results in increased activity of CASP3 protein]|vanillin inhibits the reaction [cisplatin results in increased activity of CASP3 protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
48,105303,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,9606,Homo sapiens (human),Vanillin inhibits the reaction [cadmium chloride results in decreased activity of CAT protein],,,PMID:37336463,https://www.ncbi.nlm.nih.gov/pubmed/37336463,37336463,,
49,105474,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10090,Mus musculus (house mouse),Vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein],,,PMID:26296324,https://www.ncbi.nlm.nih.gov/pubmed/26296324,26296324,,
50,105475,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [[fructose co-treated with streptozocin] results in decreased activity of CAT protein],,,PMID:33823243,https://www.ncbi.nlm.nih.gov/pubmed/33823243,33823243,,
51,105476,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347,CCL2,9606,Homo sapiens (human),"Vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
52,105477,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490,CCN2,9606,Homo sapiens (human),Vanillin results in decreased expression of CCN2 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
53,105478,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1196,CLK2,https://ctdbase.org/detail.go?type=gene&acc=1196,,,1196,CLK2,9606,Homo sapiens (human),Vanillin results in increased expression of CLK2 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
54,105479,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1471,CST3,https://ctdbase.org/detail.go?type=gene&acc=1471,,,1471,CST3,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [cisplatin results in increased expression of CST3 protein]|vanillin inhibits the reaction [methotrexate results in increased expression of CST3 protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
55,105480,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),"Vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
56,105481,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Vanillin results in increased expression of CXCL8 mRNA,,,PMID:20491607|PMID:21920952,https://www.ncbi.nlm.nih.gov/pubmed/20491607|https://www.ncbi.nlm.nih.gov/pubmed/21920952,20491607|21920952,,
57,105482,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,9606,Homo sapiens (human),Vanillin results in increased expression of CYP1A1 mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
58,105483,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548,CYP2A6,9606,Homo sapiens (human),[vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin|vanillin results in decreased activity of CYP2A6 protein|[[vanillin results in decreased activity of CYP2A6 protein] which results in decreased hydroxylation of 3-cyanocoumarin] which results in decreased chemical synthesis of 3-cyano-7-hydroxycoumarin,,,PMID:32496054,https://www.ncbi.nlm.nih.gov/pubmed/32496054,32496054,,
59,105621,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,54541,DDIT4,https://ctdbase.org/detail.go?type=gene&acc=54541,,,54541,DDIT4,9606,Homo sapiens (human),Vanillin results in increased expression of DDIT4 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
60,105622,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1789,DNMT3B,https://ctdbase.org/detail.go?type=gene&acc=1789,,,1789,DNMT3B,9606,Homo sapiens (human),Vanillin results in decreased expression of DNMT3B mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
61,105623,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848,DUSP6,9606,Homo sapiens (human),Vanillin results in decreased expression of DUSP6 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
62,105624,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356,FASLG,10116,Rattus norvegicus (Norway rat),Vanillin inhibits the reaction [methotrexate results in increased expression of FASLG protein]|vanillin inhibits the reaction [cisplatin results in increased expression of FASLG protein],,,PMID:29216766,https://www.ncbi.nlm.nih.gov/pubmed/29216766,29216766,,
63,105625,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2203,FBP1,https://ctdbase.org/detail.go?type=gene&acc=2203,,,2203,FBP1,9606,Homo sapiens (human),Vanillin binds to FBP1 protein,,,PMID:33823243,https://www.ncbi.nlm.nih.gov/pubmed/33823243,33823243,,
64,105626,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2263,FGFR2,https://ctdbase.org/detail.go?type=gene&acc=2263,,,2263,FGFR2,9606,Homo sapiens (human),Vanillin results in decreased expression of FGFR2 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
65,105627,1183,Comparative Toxicogenomics Database (CTD),Vanillin,C100058,vanillin,https://ctdbase.org/detail.go?type=chem&acc=C100058,2535,FZD2,https://ctdbase.org/detail.go?type=gene&acc=2535,,,2535,FZD2,9606,Homo sapiens (human),Vanillin results in decreased expression of FZD2 mRNA,,,PMID:17178418,https://www.ncbi.nlm.nih.gov/pubmed/17178418,17178418,,
66,113569,1183,Drug Gene Interaction database (DGIdb),Vanillin,,VANILLIN,https://www.dgidb.org/drugs/VANILLIN,,ALDH1A1,https://www.dgidb.org/genes/ALDH1A1,,,216,ALDH1A1,9606,Homo sapiens (human),,,,,,,,
67,302951,1183,IUPHAR/BPS Guide to PHARMACOLOGY,Vanillin,6412,vanillin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6412,509,TRPV3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=509,Q8K424,Transient receptor potential cation channel subfamily V member 3,246788,Trpv3,10090,Mus musculus (house mouse),Activation,,5.42,PMID:16617338,https://www.ncbi.nlm.nih.gov/pubmed/16617338,16617338,,
68,302952,1183,BindingDB,Vanillin,50177405,3-methoxy-4-hydroxybenzaldehyde,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50177405,5845,Chorismate mutase (MTB CM),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5845,P9WIB9,Secreted chorismate mutase,45425858,MCAN_RS09915,83332,Mycobacterium tuberculosis H37Rv,,IC50 (nM),24800.0,PMID:24090423,https://www.ncbi.nlm.nih.gov/pubmed/24090423,24090423,,
69,328528,1183,IUPHAR/BPS Guide to PHARMACOLOGY,Vanillin,6412,vanillin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6412,675,TAS2R39,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=675,P59534,Taste receptor type 2 member 39,259285,TAS2R39,9606,Homo sapiens (human),Agonist,pEC50,3.06,PMID:34307435,https://www.ncbi.nlm.nih.gov/pubmed/34307435,34307435,,
70,328529,1183,IUPHAR/BPS Guide to PHARMACOLOGY,Vanillin,6412,vanillin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6412,671,TAS2R20,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=671,P59543,Taste receptor type 2 member 20,259295,TAS2R20,9606,Homo sapiens (human),Agonist,pEC50,3.28,PMID:34307435,https://www.ncbi.nlm.nih.gov/pubmed/34307435,34307435,,
71,328530,1183,IUPHAR/BPS Guide to PHARMACOLOGY,Vanillin,6412,vanillin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6412,668,TAS2R14,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=668,Q9NYV8,Taste receptor type 2 member 14,50840,TAS2R14,9606,Homo sapiens (human),Agonist,pEC50,3.24,PMID:34307435,https://www.ncbi.nlm.nih.gov/pubmed/34307435,34307435,,
72,457810,1183,Toxin and Toxin Target Database (T3DB),Vanillin,T3D4849,Vanillin,http://www.t3db.ca/toxins/T3D4849,BE0001116,Stromelysin-1,http://www.t3db.ca/biodb/bio_entities/BE0001116,P08254,Stromelysin-1,4314,MMP3,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
73,457811,1183,Therapeutic Target Database (TTD),Vanillin,D0B5YS,T83193,https://idrblab.net/ttd/data/drug/details/D0B5YS,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129,MAOB,9606,Homo sapiens (human),Inhibitor,,,,,,,
74,457812,1183,Therapeutic Target Database (TTD),Vanillin,D0B5YS,T83193,https://idrblab.net/ttd/data/drug/details/D0B5YS,T59045,GABA transaminase (ABAT),https://idrblab.net/ttd/data/target/details/T59045,P80404,"4-aminobutyrate aminotransferase, mitochondrial",18,ABAT,9606,Homo sapiens (human),Inhibitor,,,,,,,
75,457813,1183,Therapeutic Target Database (TTD),Vanillin,D0B5YS,T83193,https://idrblab.net/ttd/data/drug/details/D0B5YS,T13259,Succinate-semialdehyde dehydrogenase (ALDH5A1),https://idrblab.net/ttd/data/target/details/T13259,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",7915,ALDH5A1,9606,Homo sapiens (human),Inhibitor,,,,,,,
